The Uromigos
Een podcast door The Uromigos
401 Afleveringen
-
Episode 102: Adjuvant therapy in melanoma - how it will help inform the renal community
Gepubliceerd: 28-5-2021 -
Episode 101: The Uromigos Paper of the Month - Belzutifan in renal cancer
Gepubliceerd: 26-5-2021 -
Episode 100: The Uromigos 100th Podcast - Looking to the Future
Gepubliceerd: 21-5-2021 -
Episode 99: Navigating social media from a patients' perspective
Gepubliceerd: 19-5-2021 -
Episode 98: Bladder cancer from a patient perspective
Gepubliceerd: 19-5-2021 -
Episode 97: Sacituzumab Govitecan in Bladder Cancer
Gepubliceerd: 4-5-2021 -
Episode 96: ODAC Bladder Cancer Accelerated Approval Meetings with Andrea Apolo
Gepubliceerd: 28-4-2021 -
Episode 95: ODAC Overview and Bladder Accelerated Approval Meetings with Jorge Garcia
Gepubliceerd: 28-4-2021 -
Episode 94: EIKCS Summary of Day 1
Gepubliceerd: 23-4-2021 -
Episode 93: The Uromigos Paper of the Month - A new risk classification for germ cell cancer
Gepubliceerd: 14-4-2021 -
Episode 92: Second line therapy in advanced RCC
Gepubliceerd: 9-4-2021 -
Episode 91: The Uromigos Paper of the Month - Adjuvant atezolizumab in bladder cancer
Gepubliceerd: 26-3-2021 -
Episode 90: The Uromigos Podcast with QOL Expert David Cella
Gepubliceerd: 12-3-2021 -
Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer
Gepubliceerd: 4-3-2021 -
Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler
Gepubliceerd: 26-2-2021 -
Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal
Gepubliceerd: 26-2-2021 -
Episode 86: Career Development in Academic Oncology Part 1 - Moshe Ornstein
Gepubliceerd: 26-2-2021 -
Episode 85: The CLEAR Trial
Gepubliceerd: 14-2-2021 -
Episode 84: Prostate cancer highlights from ASCO #GU21 with Chris Sweeney
Gepubliceerd: 13-2-2021 -
Episode 82: Which is the best VEGF/immune combination for first line metastatic renal cancer?
Gepubliceerd: 13-2-2021
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London